Pharmacology.
Headache treatment has been based primarily on experiences with non-specific drugs such as analgesics, non-steroidal anti-inflammatory drugs, or drugs that were originally developed to treat other diseases, such as beta-blockers and anticonvulsant medications. A better understanding of the basic pathophysiological mechanisms of migraine and other types of headache has led to the development over the past two decades of more target-specific drugs. Since activation of the trigeminovascular system and neurogenic inflammation are thought to play important roles in migraine pathophysiology, experimental studies modeling those events successfully predicted targets for selective development of pharmacological agents to treat migraine. Basically, there are two fundamental strategies for the treatment of migraine, abortive or preventive, based to a large degree on the frequency of attacks. The triptans, which exhibit potency towards selective serotonin (5-hydroxytryptamine, 5-HT) receptors expressed on trigeminal nerves, remain the most effective drugs for the abortive treatment of migraine. However, numerous preventive medications are currently available that modulate the excitability of the nervous system, particularly the cerebral cortex. In this chapter, the pharmacology of commercially available medications as well as drugs in development that prevent or abort headache attacks will be discussed.
Bolay
Hayrunnisa
H
Department of Neurology, Gazi Hospital and Neuropsychiatry Centre, Gazi University, Besevler, Ankara, Turkey. hbolay@gazi.edu.tr
Durham
Paul
P
D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006801:Humans; D008881:Migraine Disorders; D012701:Serotonin; D017366:Serotonin Receptor Agonists; D014363:Tryptamines
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D012701:Serotonin
Science. 2000 Jun 9;288(5472):1765-9
10846153
Eur J Neurol. 2006 Jun;13(6):560-72
16796580
Lancet. 2008 Dec 20;372(9656):2115-23
19036425
Nature. 1996 Dec 12;384(6609):560-4
8955268
Funct Neurol. 2000;15 Suppl 3:28-35
11200798
Curr Opin Pharmacol. 2006 Feb;6(1):68-74
16376149
Neurology. 1993 Jun;43(6 Suppl 3):S16-20
8389008
Neurology. 2002 Sep 10;59(5 Suppl 2):S2-7
12221149
Lancet. 1994 Apr 30;343(8905):1105-6
7909130
Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):160-6
1944610
Eur J Neurol. 2006 Oct;13(10):1066-77
16987158
Epilepsia. 1986 Sep-Oct;27(5):490-7
3757936
Cochrane Database Syst Rev. 2004;(2):CD003225
15106196
Ann Neurol. 2004 Jan;55(1):27-36
14705109
Nat Genet. 2003 Feb;33(2):192-6
12539047
Headache. 2007 Nov-Dec;47(10):1385-97
18052948
J Biol Chem. 2001 May 11;276(19):16083-91
11278900
Thromb Res. 2003 Jun 15;110(5-6):269-72
14592546
Eur J Pharmacol. 1997 Jun 5;328(1):37-40
9203565
J Med Chem. 1997 Oct 24;40(22):3501-3
9357515
Biochim Biophys Acta. 1999 Nov 23;1441(2-3):278-87
10570255
J Cereb Blood Flow Metab. 2002 May;22(5):620-9
11973435
Lancet. 1998 Apr 4;351(9108):1043-51
9546526
Digestion. 2001;63(2):92-101
11244247
Br J Pharmacol. 2004 Feb;141(4):580-5
14744815
J Comp Neurol. 1989 Jan 8;279(2):249-71
2563268
Neuropharmacology. 1995 Mar;34(3):255-61
7630480
Ann Neurol. 2004 Jan;55(1):19-26
14705108
Ann Neurol. 1993 Jan;33(1):48-56
8388188
Headache. 1992 Feb;32(2):101-4
1551787
Curr Opin Investig Drugs. 2003 Jul;4(7):833-40
14619405
J Neurosci. 2001 Mar 1;21(5):1750-6
11222664
Trends Mol Med. 2002 Aug;8(8):390-6
12127725
Science. 1981 Jul 10;213(4504):228-30
6166046
JAMA. 2003 Jan 1;289(1):65-9
12503978
JAMA. 2004 Jan 28;291(4):493-4
14747508
Cephalalgia. 1995;15(4):277-80
7585923
Brain Res. 2001 Oct 12;915(2):218-26
11595211
Aquat Toxicol. 2007 May 15;82(3):145-62
17382413
Neuropharmacology. 2006 Jun;50(7):845-57
16490221
FEBS Lett. 1993 Sep 13;330(2):156-60
8365485
J Neurosci. 2001 Jun 1;21(11):3721-8
11356859
FASEB J. 1997 Apr;11(5):346-54
9141501
Neurosci Lett. 1995 Jan 30;184(3):189-92
7715843
Brain. 1994 Jun;117 ( Pt 3):427-34
7518321
Neurol Sci. 2003 Dec;24(5):318-21
14716526
Trends Pharmacol Sci. 2006 Sep;27(9):467-74
16876882
Nat Med. 2002 Feb;8(2):136-42
11821897
Am J Physiol. 1989 Feb;256(2 Pt 1):E331-5
2537579
Mol Pharmacol. 1996 Aug;50(2):219-23
8700126
J Neurochem. 2001 Nov;79(4):777-86
11723170
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:535-56
12432942
Neuroscience. 1999 Mar;89(3):901-7
10199623
Pharmacotherapy. 2007 Jun;27(6):874-87
17542770
J Neurosci. 2001 Aug 15;21(16):5847-53
11487607
Trends Pharmacol Sci. 1991 Dec;12(12):444-6
1665260
Neuroscientist. 2005 Aug;11(4):373-86
16061523
Cephalalgia. 2002 May;22(4):260-4
12100087
Brain. 2002 Jun;125(Pt 6):1392-401
12023327
Br J Pharmacol. 2001 Nov;134(6):1296-302
11704650
Prostaglandins Other Lipid Mediat. 2008 Mar;85(3-4):89-99
18083054
Naunyn Schmiedebergs Arch Pharmacol. 2006 Apr;373(1):1-17
16586083
Neuroscience. 2004;123(2):491-505
14698756
Neuropharmacology. 2002 Feb;42(2):270-80
11804624
Cephalalgia. 1998 Sep;18(7):421-35
9793694
Lancet. 2005 Jul 30-Aug 5;366(9483):371-7
16054936
N Engl J Med. 2004 Mar 11;350(11):1104-10
15014183
Brain. 2001 Dec;124(Pt 12):2490-502
11701602
Eur J Pharmacol. 1989 Jun 20;165(2-3):251-8
2776831
J Neurosci. 2006 Aug 9;26(32):8332-8
16899728
Cephalalgia. 1997 Dec;17(8):833-42
9453271
Arch Neurol. 1996 Feb;53(2):180-4
8639069
J Cereb Blood Flow Metab. 1999 Nov;19(11):1270-8
10566974
Neurology. 2004 May 11;62(9):1552-7
15136680
Headache. 2006 Nov;46 Suppl 4:S171-81
17078849
Pain. 2001 Jan;89(2-3):107-10
11166465
Headache. 1994 Jul-Aug;34(7):394-9
7928323
J Neuroimmunol. 2000 Nov 1;111(1-2):122-30
11063829
J Pharmacol Exp Ther. 2004 Nov;311(2):576-84
15254142
Brain Res. 2004 Feb 13;998(1):130-5
14725976
J Clin Invest. 2004 May;113(10):1447-55
15146242
Ann Neurol. 2000 May;47(5):614-24
10805332
Peptides. 1985;6 Suppl 3:265-71
3008119
Ann Neurol. 2006 Apr;59(4):652-61
16450381
Clin Infect Dis. 2000 Oct;31 Suppl 5:S202-10
11113024
J Neurochem. 1998 Sep;71(3):1059-67
9721730
Immunology. 2002 Jan;105(1):20-2
11849311
Pathol Biol (Paris). 2000 Sep;48(7):648-57
11072643
Br J Pharmacol. 1995 Dec;116(8):3199-204
8719796
Clin Cornerstone. 2001;4(3):1-17
12739312
Brain Res. 1999 Feb 13;818(2):187-95
10082803
J Neurol. 1991;238 Suppl 1:S38-44
2045830
Brain Res Bull. 1998;45(2):189-97
9443839
Eur J Pharmacol. 1997 Jun 18;329(1):49-53
9218683
Cephalalgia. 2002 Nov;22(9):740-8
12421160
Neuroscience. 1992 Aug;49(3):669-80
1501769
J Biol Chem. 2007 Apr 20;282(16):11613-7
17329241
Cephalalgia. 2005 Apr;25(4):290-5
15773826
Annu Rev Biochem. 2000;69:145-82
10966456
J Biol Chem. 2000 Oct 20;275(42):32783-92
10869354
J Neurosci. 1987 Mar;7(3):894-903
2951504
Rev Neurol (Paris). 2005 Jul;161(6-7):655-7
16141950
Neurosci Biobehav Rev. 1997 Sep;21(5):649-78
9353797
Mol Pharmacol. 2005 Apr;67(4):1053-66
15598972
Fundam Clin Pharmacol. 1993;7(8):389-400
8294079
Pharmacol Rev. 2002 Jun;54(2):233-46
12037140
Cephalalgia. 1993 Jun;13(3):151-65
8395342
Inflamm Res. 2000 Aug;49(8):367-92
11028754
Neuropharmacology. 1999 Aug;38(8):1083-152
10462127
Prostaglandins Leukot Essent Fatty Acids. 2003 Nov;69(5):339-43
14580368
Cephalalgia. 2000 Dec;20(10):907-18
11304026
Headache. 1981 Sep;21(5):190-5
7026501
Lancet. 2001 Nov 17;358(9294):1668-75
11728541
Neuropsychiatr Dis Treat. 2008 Dec;4(6):1043-57
19337450
Cephalalgia. 1994 Oct;14(5):320-7
7828188
Neuropharmacology. 1994 Mar-Apr;33(3-4):275-317
7984267
Pharmacol Ther. 2002 Apr-May;94(1-2):77-92
12191595
Mol Pharmacol. 1993 Sep;44(3):575-82
8396718
Neuropharmacology. 1991 Nov;30(11):1193-200
1663596
Headache. 2003 Apr;43(4):376-88
12656709
Headache. 2007 Apr;47 Suppl 1:S26-43
17425708
Expert Rev Neurother. 2006 Apr;6(4):563-73
16623655
Nat Med. 1999 Feb;5(2):217-20
9930871
Acta Anaesthesiol Scand Suppl. 1995;103:1-44
7725891
Cell. 1996 Nov 1;87(3):543-52
8898206
Brain. 2005 Jan;128(Pt 1):86-97
15574468
Curr Top Med Chem. 2007;7(2):129-34
17266601
Neuroreport. 1997 Jul 7;8(9-10):2237-40
9243618
Cephalalgia. 2004 Dec;24(12):1049-56
15566419
Nature. 1983 Jul 14-20;304(5922):129-35
6346105
J Neurol. 1991;238 Suppl 1:S45-52
2045831
J Neurosci. 1988 Jul;8(7):2468-76
2470872
Trends Neurosci. 2007 Jun;30(6):284-91
17418904
Neuropeptides. 1990 Jun;16(2):69-75
2250767
Endocrine. 2006 Feb;29(1):49-60
16622292
J Biol Chem. 1996 Mar 22;271(12):6758-65
8636097
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7635-9
10393872
FASEB J. 2008 Feb;22(2):383-90
17884974
Br J Pharmacol. 2001 Aug;133(7):1029-34
11487512
J Neurosci. 1994 Aug;14(8):4987-97
7519258
Eur J Clin Pharmacol. 1994;47(4):305-9
7875179
Br J Pharmacol. 2000 Feb;129(3):420-3
10711339
CNS Neurol Disord Drug Targets. 2007 Aug;6(4):251-7
17691981
Trends Pharmacol Sci. 2007 Apr;28(4):188-95
17337068
Circulation. 2004 May 4;109(17):2068-73
15096449
N Engl J Med. 2002 Jan 24;346(4):257-70
11807151
Biochim Biophys Acta. 1995 Oct 26;1259(1):109-19
7492609
Neuropharmacology. 2002 Mar;42(4):568-76
11955527
Prog Drug Res. 1998;51:219-44
9949863
J Biol Chem. 2004 Aug 6;279(32):33684-95
15140897
Neurosci Lett. 1988 Mar 10;85(3):357-62
2966310
J Pharmacol Exp Ther. 2008 Feb;324(2):416-21
18039958
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4274-9
15016917
Ann Neurol. 2002 Apr;51(4):507-16
11921057
Nat Neurosci. 2002 Jan;5(1):34-40
11740501
Ann Neurol. 2005 Nov;58(5):698-705
16240341
Trends Neurosci. 2003 Sep;26(9):477-83
12948658
Headache. 1993 Nov-Dec;33(10):541-4
8294191
Arch Neurol. 1979 Nov;36(11):695-9
508127
Curr Top Med Chem. 2002 Jun;2(6):507-28
12052191
Brain Res. 1992 Jun 26;583(1-2):137-49
1324091
Neurol Sci. 2007 May;28 Suppl 2:S94-6
17508188
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528
11087881
J Biol Chem. 2002 Apr 19;277(16):14294-8
11847213
Mol Endocrinol. 1998 Jul;12(7):1002-9
9658404
J Neurosci. 2007 Mar 7;27(10):2693-703
17344407
Headache. 1994 Oct;34(9):497-502
8002320
Trends Pharmacol Sci. 1994 May;15(5):149-53
7538702
Arch Immunol Ther Exp (Warsz). 2000;48(6):473-80
11197601
Eur J Pharmacol. 1998 Nov 27;362(1):43-6
9865528
J Neurosci. 2001 Oct 15;21(20):8026-33
11588175
Brain Res. 2002 Jul 12;943(2):287-91
12101052
J Neurosci. 1997 Dec 15;17(24):9545-53
9391009
Nature. 1985 Jan 3-9;313(5997):54-6
3917554
Cephalalgia. 1996 Aug;16(5):310-6
8869765
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002919
16034880
Headache. 2005 Feb;45(2):144-52
15705120
Regul Pept. 1999 Feb 5;79(2-3):153-8
10100929
Ann N Y Acad Sci. 1992 Jun 30;657:88-105
1322107
Cephalalgia. 2007 Apr;27(4):315-24
17346304
Cephalalgia. 2001 Sep;21(7):781-5
11595013
Ann Neurol. 2004 Feb;55(2):276-80
14755732
Neurology. 2004 May 25;62(10):1706-11
15159466
J Comp Neurol. 1984 Feb 10;223(1):46-56
6200513
Biol Cell. 2004 Jun;96(5):343-8
15207902
Pharm World Sci. 2003 Aug;25(4):146-51
12964492
Physiol Rev. 1999 Oct;79(4):1193-226
10508233
Nat New Biol. 1971 Jun 23;231(25):232-5
5284360
Turk J Med Sci. 2016 Feb 27;47(1):343-347
28263512
Am J Physiol. 1999 Sep;277(3):H924-30
10484412
Neuroscience. 1988 Apr;25(1):195-205
2839796
J Pain. 2007 Apr;8(4):315-24
17175203
Pain. 1995 Feb;60(2):119-123
7540279
J Med Chem. 2007 Nov 15;50(23):5564-7
17929795
Brain Res. 2001 Jan 26;890(1):184-8
11164782
Cephalalgia. 1996 Jun;16(4):224-30
8792033
J Neurosci. 2002 Mar 1;22(5):RC213
11880534
Pharmacol Rev. 2001 Dec;53(4):553-68
11734618
Neuropharmacology. 2006 Sep;51(4):866-72
16846619
Crit Rev Neurobiol. 1999;13(1):45-82
10223523
Headache. 2005 Apr;45 Suppl 1:S25-32
15833087
Biochem Pharmacol. 2007 Jan 15;73(2):165-74
16959219
Science. 1985 Sep 13;229(4718):1094-7
2994212
Am Heart J. 1991 Mar;121(3 Pt 2):1006-11
1671724
Br J Pharmacol. 2001 Apr;132(7):1549-57
11264249
Neuropharmacology. 2001;40(1):75-84
11077073
Lancet. 1993 Apr 24;341(8852):1091-2
8096980
Mol Pain. 2005 Jan 17;1:3
15813989
Can J Neurol Sci. 1999 Nov;26 Suppl 3:S12-9
10563228
Nature. 2001 Mar 22;410(6827):471-5
11260714
Cephalalgia. 2007 Sep;27(9):1010-3
17681024
Cephalalgia. 2000 Jul;20(6):546-53
11075837
J Neurophysiol. 1989 Sep;62(3):802-9
2549214
Pain. 1996 Oct;67(2-3):355-9
8951929
Cephalalgia. 2003 May;23(4):287-92
12716347
Mol Pharmacol. 1993 Aug;44(2):242-6
8394988
Neurobiol Aging. 1981 Summer;2(2):83-8
6272144
Headache. 2007 Jul-Aug;47(7):1008-23; discussion 24-5
17635592
Lancet. 1991 Jul 6;338(8758):13-7
1676084
Eur J Pharmacol. 2003 Aug 15;475(1-3):69-77
12954361
N Engl J Med. 2005 Mar 17;352(11):1092-102
15713943
Eur J Pharmacol. 2004 Oct 1;500(1-3):203-19
15464034
Folia Biol (Praha). 2007;53(2):37-49
17448293
Cephalalgia. 1996 Dec;16(8):554-9
8980858
Science. 2004 May 7;304(5672):884-7
15131310
Neurology. 2008 Apr 15;70(16):1304-12
17914062
Proc Natl Acad Sci U S A. 1986 Jun;83(11):4067-70
3012548
FEBS Lett. 1985 Apr 22;183(2):403-7
2985435
Indian J Exp Biol. 2007 Jun;45(6):529-31
17585687
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5731-5
3488550
Cephalalgia. 1997 May;17(3):166-74
9170339
Trends Pharmacol Sci. 1992 Aug;13(8):307-11
1329294
Pain. 1990 Apr;41(1):71-80
2352767
Headache. 1996 May;36(5):329-31
8682677
Neurosci Lett. 2004 Aug 19;366(3):241-4
15288426
Eur J Pharmacol. 1995 Apr 4;276(3):271-6
7601213